Skip to main content
S. 73 116th Congress Senate

End Taxpayer Subsidies for Drug Ads Act

Official title: A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.

Introduced: January 10, 2019 Introduced by: Jeanne Shaheen Democratic · New Hampshire See on congress.gov
Taxation Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 10, 2019
Read twice and referred to the Committee on Finance.
Jan 10, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 10, 2019

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

End Taxpayer Subsidies for Drug Ads Act

This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.

"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.

 Related & companion bills 2
  • HR 8399 Identical bill End Taxpayer Subsidies for Drug Ads Act
  • S 1801 Affordable Medications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 17
All 17 Democratic 15 Independent 2
D
Kaine, Tim
Virginia · Feb 25, 2019
 D
Baldwin, Tammy
Wisconsin · Jan 10, 2019
 D
Bennet, Michael F.
Colorado · Jan 10, 2019
 D
Blumenthal, Richard
Connecticut · Jan 10, 2019
 D
Durbin, Richard J.
Illinois · Jan 10, 2019
 D
Gillibrand, Kirsten E.
New York · Jan 10, 2019
 D
Hassan, Margaret Wood
New Hampshire · Jan 10, 2019
 D
Hirono, Mazie K.
Hawaii · Jan 10, 2019
 I
King, Angus S., Jr.
Maine · Jan 10, 2019
 D
Klobuchar, Amy
Minnesota · Jan 10, 2019
 D
Reed, Jack
Rhode Island · Jan 10, 2019
 I
Sanders, Bernard
Vermont · Jan 10, 2019
 D
Schatz, Brian
Hawaii · Jan 10, 2019
 D
Smith, Tina
Minnesota · Jan 10, 2019
 D
Van Hollen, Chris
Maryland · Jan 10, 2019
 D
Warren, Elizabeth
Massachusetts · Jan 10, 2019
 D
Whitehouse, Sheldon
Rhode Island · Jan 10, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 73: End Taxpayer Subsidies for Drug Ads Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-73/
MLA
"S. 73: End Taxpayer Subsidies for Drug Ads Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-73/.
Bluebook (legal)
S. 73, 116th Cong. (2026), https://openamerica.io/bill/116-S-73/.
Markdown link
[S. 73: End Taxpayer Subsidies for Drug Ads Act](https://openamerica.io/bill/116-S-73/)
Report a problem